US Drugmakers to Raise Prices on Over 350 Medications in 2026
According to analytics firm 3 Axis Advisors, drugmakers in the United States plan to raise prices on at least 350 branded medicines, including vaccines for COVID-19, RSV and shingles, as well as the cancer drug Ibrance, despite pressure from the Trump …